Abstract:A bstract It is well known that viruses make extensive use of the host cell’s machinery, hijacking it for the purpose of viral replication and interfere with the activity of master regulatory proteins – including RNA binding proteins (RBPs). RBPs recognize and bind RNA molecules to control several steps of cellular RNA metabolism, such as splicing, transcript stability, translation and others, and recognize their targets by means of sequence or structure motifs. Host RBPs are critical factors for viral replication, especially for RNA viruses, and have been shown to influence viral RNA stability, replication and escape of host immune response. While current research efforts have been centered around identifying mechanisms of host cell-entry, the role of host RBPs in the context of SARS-CoV-2 replication remains poorly understood. Few experimental studies have started mapping the SARS-CoV-2 RNA-protein interactome in infected human cells, but they are limited in the resolution and exhaustivity of their output. On the other hand, computational approaches enable screening of large numbers of human RBPs for putative interactions with the viral RNA, and are thus crucial to prioritize candidates for further experimental investigation. Here, we investigate the role of RBPs in the context of SARS-CoV-2 by constructing a first single-nucleotide in silico map of human RBP / viral RNA interactions by using deep learning models trained on RNA sequences. Our framework is based on Pysster and DeepRiPe, two deep learning method which use a convolutional neural network to learn sequence-structure preferences of a specific RBP. Models were trained using eCLIP and PAR-CLIP datasets for >150 RBP generated on human cell lines and applied cross-species to predict the propensity of each RBP to bind the SARS-CoV-2 genome. After extensive validation of predicted binding sites, we generate RBP binding profiles across different SARS-CoV-2 variants and 6 other betacoronaviruses. We address the questions of (1) conservation of binding between pathogenic betacoronaviruses, (2) differential binding across viral strains and (3) gain and loss of binding events in novel mutants which can be linked to disease severity and spread in the population. In addition, we explore the specific pathways hijacked by the virus, by integrating host factors linked to these virus-binding RBPs through protein-protein interaction networks or genome wide CRISPR screening. We believe that identifying viral RBP binding sites will give valuable insights into the mechanisms of host-virus interaction, thus giving us a deeper understanding of the life cycle of SARS-CoV-2 but also opening new avenues for the development of new therapeutics.

Computational Mapping of the Human-SARS-CoV-2 Protein-RNA Interactome

A computational map of the human-SARS-CoV-2 protein–RNA interactome predicted at single-nucleotide resolution

A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells

CoVM2: Molecular Biological Data Integration of SARS-CoV-2 Proteins in a Macro-to-Micro Method.

The SARS-CoV-2 RNA interactome

Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions

The SARS-CoV-2 RNA–protein interactome in infected human cells

Mapping the host protein interactome of non-coding regions in SARS-CoV-2 genome

A map of binary SARS-CoV-2 protein interactions implicates host immune regulation and ubiquitination

Defining distinct RNA-protein interactomes of SARS-CoV-2 genomic and subgenomic RNAs

Characterization and functional interrogation of the SARS-CoV-2 RNA interactome

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions

The short- and long-range RNA-RNA Interactome of SARS-CoV-2

Structural analysis of SARS-CoV-2 and prediction of the human interactome

Atlas of interactions between SARS-CoV-2 macromolecules and host proteins

In Vivostructural Characterization of the Whole SARS-CoV-2 RNA Genome Identifies Host Cell Target Proteins Vulnerable to Re-Purposed Drugs

Discovery and Functional Interrogation of the Virus and Host RNA Interactome of SARS-Cov-2 Proteins

In Vivo Structural Characterization of the SARS-CoV-2 RNA Genome Identifies Host Proteins Vulnerable to Repurposed Drugs.

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity